EUS-guided radiofrequency and ethanol ablation of pancreatic insulinomas: a single-center experience.

ABSTRACT:

Background

Insulinomas are the most common functional pancreatic neuroendocrine tumors (pNETs). Minimally invasive approaches like endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) and ethanol ablation (EUS-EA) are emerging treatment options for small insulinomas (<2 cm).

Objectives

To assess the safety, efficacy, and long-term outcomes of EUS-RFA and EUS-EA in treating small pancreatic insulinomas.

Design

A retrospective, single-center study of nine patients diagnosed with insulinomas and treated with EUS ablation methods.

Methods

Nine lesions (mean size 11 mm; range: 6-19 mm) were treated with EUS-RFA (n = 7) or EUS-EA (n = 2). EUS-RFA procedures had a mean ablation time of 31 s (range: 17-69 s), while EUS-EA used a mean ethanol vol

SUBMITTER: Kozlowska K 

PROVIDER: S-EPMC12708985 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature